Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-49499
Mar Drugs 2020 Nov 09;1811:. doi: 10.3390/md18110557.
Show Gene links Show Anatomy links

Pharmacokinetics of Marine-Derived Drugs.

Shikov AN , Flisyuk EV , Obluchinskaya ED , Pozharitskaya ON .


???displayArticle.abstract???
Marine organisms represent an excellent source of innovative compounds that have the potential for the development of new drugs. The pharmacokinetics of marine drugs has attracted increasing interest in recent decades due to its effective and potential contribution to the selection of rational dosage recommendations and the optimal use of the therapeutic arsenal. In general, pharmacokinetics studies how drugs change after administration via the processes of absorption, distribution, metabolism, and excretion (ADME). This review provides a summary of the pharmacokinetics studies of marine-derived active compounds, with a particular focus on their ADME. The pharmacokinetics of compounds derived from algae, crustaceans, sea cucumber, fungus, sea urchins, sponges, mollusks, tunicate, and bryozoan is discussed, and the pharmacokinetics data in human experiments are analyzed. In-depth characterization using pharmacokinetics is useful for obtaining information for understanding the molecular basis of pharmacological activity, for correct doses and treatment schemes selection, and for more effective drug application. Thus, an increase in pharmacokinetic research on marine-derived compounds is expected in the near future.

???displayArticle.pubmedLink??? 33182407
???displayArticle.pmcLink??? PMC7698100
???displayArticle.link??? Mar Drugs
???displayArticle.grants??? [+]



???attribute.lit??? ???displayArticles.show???
References [+] :
Aherne, Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay. 1996, Pubmed